Suvorexant for the treatment of insomnia.

Suvorexant for the treatment of insomnia.

Item
http://www.wikidata.org/entity/Q34443676
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexantClinical management of sleep disturbances in Alzheimer's disease: current and emerging strategiesThe Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems.Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction.G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease.Orexin OX2 Receptor Antagonists as Sleep Aids.Is suvorexant a better choice than alternative hypnotics?Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders.Simple and Highly Sensitive UPLC-ESI-MS/MS Assay for Rapid Determination of Suvorexant in Plasma.Orexin Receptor Antagonists
P2860

Suvorexant for the treatment of insomnia.

Item
http://www.wikidata.org/entity/Q34443676
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Suvorexant for the treatment of insomnia.
@ast
Suvorexant for the treatment of insomnia.
@en
Suvorexant for the treatment of insomnia.
@nl
type
label
Suvorexant for the treatment of insomnia.
@ast
Suvorexant for the treatment of insomnia.
@en
Suvorexant for the treatment of insomnia.
@nl
prefLabel
Suvorexant for the treatment of insomnia.
@ast
Suvorexant for the treatment of insomnia.
@en
Suvorexant for the treatment of insomnia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Suvorexant for the treatment of insomnia.
@en
P2093
P2860
P304
P31
P356
10.1586/17512433.2014.966813
P407
P433
P478
P50
P577
P698